AbbVie预测利润会提高, 原因是新免疫药物的强劲销售, AbbVie boosts profit forecast due to strong sales of new immunology drugs, lifting stock.

AbbVie是一家主要的制药公司,由于大量销售最新的免疫药物,因此提高了利润预测。 AbbVie, a major pharmaceutical company, has raised its profit forecast due to strong sales of its newer immunology drugs. 该公司的股票在宣布后上涨,因为金融前景的改善表明业绩比预期好。 The company's stock rose following this announcement, as the improved financial outlook suggests better-than-expected performance. 尽管对关税感到关切,但AbbVie对其金融前景仍然乐观。 Despite concerns about tariffs, AbbVie remains optimistic about its financial prospects.